Literature DB >> 11085879

Oligodendrocyte precursor migration and differentiation: combined effects of PSA residues, growth factors, and substrates.

L Decker1, V Avellana-Adalid, B Nait-Oumesmar, P Durbec, A Baron-Van Evercooren.   

Abstract

Using the oligosphere strategy (V. Avellana-Adalid et al., 1996, J. Neurosci. Res. 45, 558-570), we compared the migratory behavior of oligodendrocyte preprogenitors (OPP) that expressed the polysialylated form of the neural cell adhesion molecule (PSA-NCAM) and of GD3-positive oligodendrocyte progenitors (OP). To study the role of PSA in OPP migration, we used endoneuraminidase-N, which specifically cleaves PSA from NCAM. Kinetic data showed that (i) migration velocity decreased with time and was favored on polyornithine compared to Matrigel; (ii) cells emerging from spheres enriched in PSA-NCAM+ OPP migrated farther than those from spheres enriched in GD3+ OP, their migration being enhanced by the addition of growth factors; (iii) removal of PSA from NCAM moderately reduced OPP migration and induced their differentiation in GD3+ OP and GFAP+ astrocytes; (iv) blocking integrins reduced their migration, suggesting an alternative mechanism of migration. Altogether these data illustrate that motility and differentiation of OPP involve the combinatorial action of PSA-NCAM, molecules of the ECM and their receptors, and growth factors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11085879     DOI: 10.1006/mcne.2000.0885

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  23 in total

1.  Expression of stathmin, a developmentally controlled cytoskeleton-regulating molecule, in demyelinating disorders.

Authors:  Aixiao Liu; Christine Stadelmann; Mario Moscarello; Wolfgang Bruck; Andre' Sobel; Fabrizio G Mastronardi; Patrizia Casaccia-Bonnefil
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

Review 2.  Cell therapy for multiple sclerosis.

Authors:  Tamir Ben-Hur
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

Review 3.  The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.

Authors:  T E VanMeter; H K Rooprai; M M Kibble; H L Fillmore; W C Broaddus; G J Pilkington
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

Review 4.  Extracellular cues influencing oligodendrocyte differentiation and (re)myelination.

Authors:  Natalie A Wheeler; Babette Fuss
Journal:  Exp Neurol       Date:  2016-03-23       Impact factor: 5.330

5.  Robust generation of oligodendrocyte progenitors from human neural stem cells and engraftment in experimental demyelination models in mice.

Authors:  Margherita Neri; Claudio Maderna; Daniela Ferrari; Chiara Cavazzin; Angelo L Vescovi; Angela Gritti
Journal:  PLoS One       Date:  2010-04-12       Impact factor: 3.240

6.  Ectopic expression of polysialylated neural cell adhesion molecule in adult macaque Schwann cells promotes their migration and remyelination potential in the central nervous system.

Authors:  C Bachelin; V Zujovic; D Buchet; J Mallet; A Baron-Van Evercooren
Journal:  Brain       Date:  2009-10-20       Impact factor: 13.501

Review 7.  Regulation of oligodendrocyte precursor migration during development, in adulthood and in pathology.

Authors:  Fernando de Castro; Ana Bribián; Maria Cristina Ortega
Journal:  Cell Mol Life Sci       Date:  2013-05-21       Impact factor: 9.261

Review 8.  Cell migration in the normal and pathological postnatal mammalian brain.

Authors:  Myriam Cayre; Peter Canoll; James E Goldman
Journal:  Prog Neurobiol       Date:  2009-02-11       Impact factor: 11.685

9.  GABA and neuroactive steroid interactions in glia: new roles for old players?

Authors:  Valerio Magnaghi
Journal:  Curr Neuropharmacol       Date:  2007-03       Impact factor: 7.363

10.  Down-regulation of the axonal polysialic acid-neural cell adhesion molecule expression coincides with the onset of myelination in the human fetal forebrain.

Authors:  I Jakovcevski; Z Mo; N Zecevic
Journal:  Neuroscience       Date:  2007-08-08       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.